Artia Global Partners LP bought a new stake in Prometheus Biosciences, Inc. (NASDAQ:RXDX – Get Rating) during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 22,321 shares of the biopharmaceutical company’s stock, valued at approximately $2,455,000. Prometheus Biosciences accounts for […]
Altfest L J & Co. Inc. trimmed its holdings in iShares Global Consumer Staples ETF (NYSEARCA:KXI – Get Rating) by 17.0% in the 4th quarter, according to its most recent filing with the SEC. The institutional investor owned 6,471 shares of the company’s stock after selling 1,322 shares during the quarter. Altfest L J & […]
Dupont Capital Management Corp lowered its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Rating) by 83.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 517 shares of the biotechnology company’s stock after selling 2,649 shares during the quarter. Dupont Capital Management Corp’s […]
Bard Financial Services Inc. lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 12.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 350 shares of the biopharmaceutical company’s stock after selling 50 shares during the period. Bard Financial Services Inc.’s holdings […]
Bard Financial Services Inc. lifted its position in Taiwan Semiconductor Manufacturing Company Limited (NYSE:TSM – Get Rating) by 8.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 24,963 shares of the semiconductor company’s stock after acquiring an additional […]